Mitesco PE Ratio 2015-2025 | MITI
Current and historical p/e ratio for Mitesco (MITI) from 2015 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Mitesco PE ratio as of August 29, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Mitesco PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-28 | 0.13 | 0.62 | |
| 2025-06-30 | 0.28 | $0.21 | 1.33 |
| 2025-03-31 | 0.46 | $0.06 | 7.67 |
| 2024-12-31 | 0.46 | $0.03 | 15.33 |
| 2024-09-30 | 0.27 | $0.03 | 9.00 |
| 2024-06-30 | 0.12 | $-0.65 | 0.00 |
| 2024-03-31 | 0.35 | $-2.05 | 0.00 |
| 2023-12-31 | 0.03 | $-3.12 | 0.00 |
| 2023-09-30 | 0.03 | $-3.12 | 0.00 |
| 2023-06-30 | 1.18 | $-3.73 | 0.00 |
| 2023-03-31 | 1.24 | $-3.18 | 0.00 |
| 2022-12-31 | 1.06 | $-3.00 | 0.00 |
| 2022-09-30 | 5.50 | $-4.50 | 0.00 |
| 2022-06-30 | 6.50 | $-4.00 | 0.00 |
| 2022-03-31 | 12.00 | $-3.50 | 0.00 |
| 2021-12-31 | 8.00 | $-3.00 | 0.00 |
| 2021-09-30 | 13.00 | $-2.00 | 0.00 |
| 2021-06-30 | 10.00 | $-2.00 | 0.00 |
| 2021-03-31 | 14.00 | $-1.50 | 0.00 |
| 2020-12-31 | 1.50 | $-1.00 | 0.00 |
| 2020-09-30 | 1.50 | $-0.50 | 0.00 |
| 2020-06-30 | 2.00 | 0 | 0.00 |
| 2020-03-31 | 1.50 | 0 | 0.00 |
| 2019-12-31 | 2.50 | 0 | 0.00 |
| 2019-09-30 | 1.50 | 0 | 0.00 |
| 2019-06-30 | 4.50 | 0 | 0.00 |
| 2019-03-31 | 3.50 | $-0.50 | 0.00 |
| 2018-12-31 | 5.00 | $-0.50 | 0.00 |
| 2018-09-30 | 7.00 | $-1.00 | 0.00 |
| 2018-06-30 | 4.50 | $-1.50 | 0.00 |
| 2018-03-31 | 5.00 | $-2.00 | 0.00 |
| 2017-12-31 | 5.00 | $-2.50 | 0.00 |
| 2017-09-30 | 9.50 | $-5.50 | 0.00 |
| 2017-06-30 | 12.00 | $-7.50 | 0.00 |
| 2017-03-31 | 27.00 | $-14.00 | 0.00 |
| 2016-12-31 | 9.50 | $-17.00 | 0.00 |
| 2016-09-30 | 15.00 | $-13.50 | 0.00 |
| 2016-06-30 | 38.50 | $-11.00 | 0.00 |
| 2016-03-31 | 74.50 | $-3.50 | 0.00 |
| 2015-12-31 | 50.50 | 0 | 0.00 |
| 2015-09-30 | 101.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.001B | $0.000B |
| Mitesco Inc. is holding company for MyCare, LLC. It is building out a network of clinics using telehealth technology with the nurse practitioner operating as its primary healthcare provider. Mitesco Inc., formerly known as True Nature Holding Inc., is based in Denver, CO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.502B | 54.47 |
| Doximity (DOCS) | United States | $12.809B | 56.99 |
| Tempus AI (TEM) | United States | $12.797B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.972B | 81.70 |
| IRhythm Technologies (IRTC) | United States | $5.509B | 0.00 |
| Hinge Health (HNGE) | United States | $4.528B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.705B | 39.76 |
| Privia Health (PRVA) | United States | $2.677B | 198.27 |
| Heartflow (HTFL) | $2.609B | 0.00 | |
| Phreesia (PHR) | United States | $1.937B | 0.00 |
| 10x Genomics (TXG) | United States | $1.778B | 0.00 |
| Enovis (ENOV) | United States | $1.749B | 9.24 |
| Omnicell (OMCL) | United States | $1.529B | 29.45 |
| Schrodinger (SDGR) | United States | $1.454B | 0.00 |
| Azenta (AZTA) | United States | $1.372B | 59.84 |
| Clover Health Investments (CLOV) | United States | $1.348B | 0.00 |
| Claritev (CTEV) | United States | $1.174B | 0.00 |
| Evolent Health (EVH) | United States | $1.133B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.674B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.410B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.60 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.164B | 0.00 |
| CareCloud (CCLD) | United States | $0.160B | 7.27 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.082B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |